|
What the numbers say: In 2020, approximately 42% of surveyed adults in the U.S. expressed a willingness to use marijuana for medical purposes, reflecting a significant portion of the population, the USA Rx revealed. Similarly, 17% of adults were ready to explore the potential medical benefits of psychedelics. Relevance: Data indicates a growing interest in alternative treatments and a willingness to explore non-traditional approaches to address medical conditions. The findings suggest a potential shift in public attitude toward the therapeutic value of marijuana and psychedelics. Which brands should care: Pharmaceutical companies, cannabis businesses, psychedelic therapy providers, healthcare institutions, and wellness/alternative medicine brands should note the willingness expressed by adults in the U.S. to try marijuana and psychedelics for medical purposes. |
